Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     

  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    50,784.56
    +1,613.14 (+3.28%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     
MONEY:

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

BUZZ-Vernalis: Tuzistra XR green light hoists stock to 5-yr high

Reuters - UK Focus

** Pharma co Vernalis (Stuttgart: BBP2.SG - news) up c.15 pct at 5-yr high & on track for biggest one-day rise since Aug 2014

** FDA approves co's first cough/cold medicine Tuzistra XR

** News sparks target price hikes from Stifel (74p vs 63p), Peel Hunt (68p vs 62p) & Canaccord Genuity (92p vs 66p)

** Share (LSE: SHRE.L - news) price rise adds c.$53 mln to co's market value (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)